Case study

Bridging company constraints and patient reality.

A patient-led insight and go-to-market project for a French precision psychiatry diagnostics company.

At a glance

Patient insight and adoption strategy for myEDIT-B.

Partner

Alcediag

A French precision psychiatry diagnostics company.

Product context

myEDIT-B

A blood test intended to help differentiate depression from bipolarity.

HopeStage role

Patient insight and adoption

Qualitative research, segmentation, language, positioning and go-to-market recommendations.

The challenge

Scientific validity alone does not determine adoption.

People need to understand what a test means, what it does not mean, how it relates to diagnosis and identity, and whether communication feels respectful and safe.

Patient trust

Understand concerns around identity, diagnosis, uncertainty and respectful communication.

Audience segmentation

Differentiate the needs of people affected by depression, bipolarity and loved ones.

Company constraints

Connect patient reality with practical positioning, funnel and go-to-market choices.

Approach

Six methods, one decision-ready strategy.

  1. 01

    Qualitative interviews

  2. 02

    Survey and community distribution design

  3. 03

    Focus group methodology

  4. 04

    Personas and journey mapping

  5. 05

    Positioning and messaging

  6. 06

    Marketing funnel and go-to-market recommendations

What changed

Insight became clearer language and direction.

Deliverables

A reusable evidence and implementation toolkit.

Approved testimonial

Patient insight should change the strategy, not decorate it.

Clément helped us understand the need of the patient and how to address it properly and respectfully.
Alexandra Prieux, CEO at Alcediag